Trastuzumab Active Not Recruiting Phase 3 Trials for HER2/Neu Positive / Ductal Breast Carcinoma In Situ Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00769379Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy